SG Capital Management LLC Takes $30.29 Million Position in Maximus, Inc. (NYSE:MMS)

SG Capital Management LLC bought a new stake in shares of Maximus, Inc. (NYSE:MMS) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 405,689 shares of the health services provider’s stock, valued at approximately $30,285,000. Maximus accounts for 2.9% of SG Capital Management LLC’s portfolio, making the stock its 7th biggest holding.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. UMB Bank n.a. lifted its position in Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 158 shares during the last quarter. V Square Quantitative Management LLC increased its stake in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after buying an additional 180 shares during the period. Hillsdale Investment Management Inc. increased its stake in shares of Maximus by 0.4% in the fourth quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider’s stock worth $3,912,000 after buying an additional 230 shares during the period. Bridge City Capital LLC raised its holdings in Maximus by 0.9% during the 4th quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider’s stock valued at $2,128,000 after buying an additional 254 shares during the last quarter. Finally, Inspire Advisors LLC boosted its position in Maximus by 3.1% during the 4th quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider’s stock valued at $646,000 after buying an additional 258 shares during the period. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Up 0.4%

Shares of NYSE:MMS opened at $75.34 on Friday. The stock’s 50-day moving average is $68.58 and its 200 day moving average is $72.84. The company has a market cap of $4.26 billion, a PE ratio of 16.20 and a beta of 0.61. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.64. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $1.57 EPS. Sell-side analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus’s payout ratio is currently 23.86%.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Thursday.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.